How Many Units Is 5mg of Mounjaro, and What Do the Pen Markings Mean?

You've just been prescribed 5mg, and the pen window shows numbers you weren't expecting

It's a common moment: your first 5mg Mounjaro pen arrives, you hold it up to the light, and the window shows markings that don't obviously read "5mg". You were told you're on 5mg. So what are all these numbers?

The Mounjaro KwikPen is filled with 3 ml of tirzepatide solution. That 3 ml contains 40 units of fluid. The pen is designed to deliver four equal portions of 10 units each, once a week. Over four weeks, the window will gradually fall from full to empty as each 10-unit dose is used. At 5mg strength, those 10 units carry exactly 5mg of tirzepatide, the concentration of the solution is calibrated so the maths works out precisely.

A practical check you can do in under a minute: hold the pen horizontally at eye level before each injection and look at the liquid level in the window. It should drop by roughly one quarter of the total fill with each weekly dose. If the level looks the same as it did before you injected, or if you notice air bubbles the size of a pencil tip or larger, call your prescriber before the next dose. The NHS tirzepatide page has guidance on what to do if something looks wrong.

The pen itself handles the dose delivery automatically. You press the injection button until you hear the first click, hold it in place, and the device does the rest. You are not drawing up 10 units manually, the pen does not work that way. Understanding the unit count is useful context; it is not an instruction to measure anything yourself.

Why 40 units across every strength, and what changes between pens

This is the detail that trips people up most often. Whether you are using the 2.5mg starter pen or the 15mg maintenance pen, the unit count is identical: 40 units per pen, 10 units per weekly dose. What changes is the concentration of tirzepatide dissolved in that solution, not the volume you inject.

So a 5mg pen and a 7.5mg pen both deliver 10 units of fluid per dose. The 7.5mg pen simply holds more tirzepatide per unit. This is why Mounjaro pens are not interchangeable, using a higher-strength pen on a lower prescribed dose is not a workaround; it would deliver the wrong therapeutic amount entirely. If you want to understand how the unit count maps across to a different strength, the detail for the 7.5mg pen follows the same 40-unit architecture.

Eli Lilly designed the KwikPen this way so that the injection technique stays consistent regardless of dose. The same press, the same hold, the same site rotation, all of it remains unchanged as your prescriber moves you up through the titration schedule. You can read more about how the full dosage structure works across Mounjaro's six strengths on our Mounjaro dosage levels page.

It is also worth knowing that tirzepatide is the active ingredient sold under the Mounjaro brand name in the UK. If you have seen references to "units" in the context of tirzepatide more generally, the arithmetic is the same, the units in 5mg of tirzepatide are identical to those in 5mg of Mounjaro because they are the same medicine.

Is 5mg the right place to be on the titration ladder?

Most people reach 5mg after four weeks at 2.5mg. The starting dose exists primarily to let the body adjust (nausea and other gastrointestinal effects tend to settle during that first month) rather than to drive significant weight change. Moving to 5mg is the first step into the therapeutic range.

How long someone stays at 5mg, and whether they move higher, is a clinical decision. NICE's appraisal of tirzepatide, TA1026, notes that treatment should be reviewed if less than 5% weight loss is achieved after six months at the highest tolerated dose. That review sits with your prescriber, not with the pen in your fridge. Dose increases require clinical reassessment; at nume, every repeat order goes through fresh review by a GPhC-registered Independent Prescriber before dispatch.

If you are curious about what comes before 5mg, the 2.5mg pen's unit breakdown follows the same logic. And for those considering the overall picture of private treatment costs as doses increase, our page covering the Eli Lilly UK price changes has context worth reading before your next order. For a broader overview of the treatment itself, the Mounjaro treatment page is a good starting point.

When to ask your prescriber rather than the pen markings

The pen window tells you how much solution remains. It does not tell you whether a dose is working, whether it is time to move up, or whether a side effect you noticed this week is worth reporting. Those questions belong to your clinical team.

Common side effects at 5mg (nausea, loose stools, fatigue in the day or two after an injection) are generally the same GI-led profile seen across all Mounjaro doses, typically more noticeable after a dose increase and settling within a week or two for most people. If symptoms are severe, persistent, or include upper abdominal pain that does not ease, contact your prescriber promptly. Suspected side effects can also be reported directly through the MHRA Yellow Card scheme.

If you have specific questions about how your pen looks or behaves (solution colour, an unexpected reading in the window, or anything that does not match the leaflet) reach out via our support team, available seven days a week. And if you are still deciding whether Mounjaro is the right route for you, our free consultation is the place to start that conversation with a prescriber.